Literature DB >> 19966140

Single- and repeated-dose oral toxicity studies of citicoline free-base (choline cytidine 5'-pyrophosphate) in Sprague-Dawley rats.

A G Schauss1, S Somfai-Relle, I Financsek, R Glavits, S C Parent, J R Endres, T Varga, Z Szücs, A Clewell.   

Abstract

The dietary supplement Citicoline free-base (choline cytidine 5'-pyrophosphate) was toxicologically evaluated in Sprague-Dawley rats using oral gavage. In an acute 14-day study, 2000 mg/kg was well tolerated. In a 90-day study, 100, 350, and 1000 mg/kg/day doses resulted in no mortality. In males, slight significant increases in serum creatinine (350 and 1000 mg/kg/day), and decreases in urine volume (all treated groups) were observed. In females, slight significant increases in total white blood cell and absolute lymphocyte counts (1000 mg/kg/day), and blood urea nitrogen (BUN) (100 and 350, but not 1000 mg/kg/day) were noted. A dose-related increase in renal tubular mineralization, without degenerative or inflammatory reaction, was found in females (all treated groups) and two males (1000 mg/kg/day). Renal mineralization in rats (especially females) is influenced by calcium:phosphorus ratios in the diet. A high level of citicoline consumption resulted in increased phosphorus intake in the rats, and likely explains this result.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966140     DOI: 10.1177/1091581809349452

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  7 in total

1.  Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control.

Authors:  Yolandi van der Merwe; Matthew C Murphy; Jeffrey R Sims; Muneeb A Faiq; Xiao-Ling Yang; Leon C Ho; Ian P Conner; Yu Yu; Christopher K Leung; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

2.  Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Eri Nakazaki; Eunice Mah; Kristen Sanoshy; Danielle Citrolo; Fumiko Watanabe
Journal:  J Nutr       Date:  2021-08-07       Impact factor: 4.798

Review 3.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

4.  Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke.

Authors:  Huanling Liu; Anna Jablonska; Yuguo Li; Suyi Cao; Dexiang Liu; Hanwei Chen; Peter Cm Van Zijl; Jeff W M Bulte; Miroslaw Janowski; Piotr Walczak; Guanshu Liu
Journal:  Theranostics       Date:  2016-06-18       Impact factor: 11.556

Review 5.  Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives.

Authors:  Gloria Roberti; Lucia Tanga; Manuele Michelessi; Luciano Quaranta; Vincenzo Parisi; Gianluca Manni; Francesco Oddone
Journal:  Int J Mol Sci       Date:  2015-11-30       Impact factor: 5.923

Review 6.  Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.

Authors:  Vincenzo Parisi; Francesco Oddone; Lucia Ziccardi; Gloria Roberti; Gianluca Coppola; Gianluca Manni
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 7.  Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review.

Authors:  Francesco Oddone; Luca Rossetti; Mariacristina Parravano; Diego Sbardella; Massimo Coletta; Lucia Ziccardi; Gloria Roberti; Carmela Carnevale; Dario Romano; Gianluca Manni; Vincenzo Parisi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.